Keith R. Yamamoto Ph.D.
|Age||Total Calculated Compensation||This person is connected to 37 board members in 5 different organizations across 3 different industries.|
See Board Relationships
Dr. Keith R. Yamamoto, Ph.D., founded the journal Molecular Biology of the Cell and served as an Associate Editor, Editor, and Editor-in-Chief from 1989 to 2003. Dr. Yamamoto has been the Chairman of Scientific Advisory Board and Member of Scientific Advisory Board of Sirna Therapeutics Inc. from March 2005 to 2007. He oversees the Yamamoto Lab, which is interested in mechanisms by which gene transcription is regulated in different cell types and physiological (or pathological) ...
Princeton UniversityPhone: 609-258-3000
Princeton, New Jersey 08544
Board Members Memberships*There is no Board Members Memberships data available.
University of California-San Francisco
Bachelor's Degree 1968
Iowa State University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|John Michael Maslowski||Chief Executive Officer and Director|
Fibrocell Science, Inc.
|Kenneth T. Mills||Chief Executive Officer, President, Director and Member of Disclosure Committee|
|Matthew Kapusta||Chief Executive Officer and Member of Management Board|
|Katrine S. Bosley||Chief Executive Officer, President and Director|
Editas Medicine, Inc.
|Steven M. Paul M.D.||Chief Executive Officer, President and Director|
Voyager Therapeutics, Inc.
|$450.0K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.